Financing, Equity Capital Markets

Ocular Therapeutix, Inc.

01/18
|
$37.4 Million
Piper Sandler served as sole bookrunner for Ocular Therapeutix, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma